Literature DB >> 28544326

Haploinsufficiency of NR4A2 is associated with a neurodevelopmental phenotype with prominent language impairment.

Miriam S Reuter1, Mandy Krumbiegel1, Gregor Schlüter2, Arif B Ekici1, André Reis1, Christiane Zweier1.   

Abstract

Non-recurrent deletions in 2q24.1, minimally overlapping two genes, NR4A2 and GPD2, were recently described in individuals with language impairment and behavioral and cognitive symptoms. We herewith report on a female patient with a similar phenotype of severe language and mild cognitive impairment, in whom we identified a de novo deletion covering only NR4A2. NR4A2 encodes a transcription factor highly expressed in brain regions critical for speech and language and implicated in dopaminergic neuronal development. Our findings of a de novo deletion of NR4A2 in an individual with mild intellectual disability and prominent speech and language impairment provides further evidence for NR4A2 haploinsufficiency being causative for neurodevelopmental and particularly language phenotypes.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  dopamine; dopaminergic modulation; intellectual disability; nurr1; speech and language development; transcription factor

Mesh:

Substances:

Year:  2017        PMID: 28544326     DOI: 10.1002/ajmg.a.38288

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

Review 1.  The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes.

Authors:  Alessio Di Fonzo; Alberto Albanese; Hyder A Jinnah
Journal:  Curr Opin Neurol       Date:  2022-07-05       Impact factor: 6.283

2.  Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium.

Authors:  Bernt Popp; Mandy Krumbiegel; Janina Grosch; Annika Sommer; Steffen Uebe; Zacharias Kohl; Sonja Plötz; Michaela Farrell; Udo Trautmann; Cornelia Kraus; Arif B Ekici; Reza Asadollahi; Martin Regensburger; Katharina Günther; Anita Rauch; Frank Edenhofer; Jürgen Winkler; Beate Winner; André Reis
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

3.  Heterozygous loss of function of NR4A2 is associated with intellectual deficiency, rolandic epilepsy, and language impairment.

Authors:  Luiza L P Ramos; Fabiola P Monteiro; Leticia P B Sampaio; Larissa A Costa; Mara D O Ribeiro; Erika L Freitas; Joao P Kitajima; Fernando Kok
Journal:  Clin Case Rep       Date:  2019-07-11

4.  Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes.

Authors:  Pamela Feliciano; Xueya Zhou; Irina Astrovskaya; Tychele N Turner; Tianyun Wang; Leo Brueggeman; Rebecca Barnard; Alexander Hsieh; LeeAnne Green Snyder; Donna M Muzny; Aniko Sabo; Richard A Gibbs; Evan E Eichler; Brian J O'Roak; Jacob J Michaelson; Natalia Volfovsky; Yufeng Shen; Wendy K Chung
Journal:  NPJ Genom Med       Date:  2019-08-23       Impact factor: 8.617

Review 5.  NURR1 Alterations in Perinatal Stress: A First Step towards Late-Onset Diseases? A Narrative Review.

Authors:  Laura Bordoni; Irene Petracci; Jean Calleja-Agius; Joan G Lalor; Rosita Gabbianelli
Journal:  Biomedicines       Date:  2020-12-08

6.  Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study.

Authors:  Elizabeth Ruiz-Sánchez; Janet Jiménez-Genchi; Yessica M Alcántara-Flores; Carlos J Castañeda-González; Carlos L Aviña-Cervantes; Petra Yescas; María Del Socorro González-Valadez; Nancy Martínez-Rodríguez; Antonio Ríos-Ortiz; Martha González-González; María E López-Navarro; Patricia Rojas
Journal:  BMC Psychiatry       Date:  2021-02-09       Impact factor: 3.630

7.  NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblast.

Authors:  Natasha de Alwis; Sally Beard; Natalie K Binder; Natasha Pritchard; Tu'uhevaha J Kaitu'u-Lino; Susan P Walker; Owen Stock; Katie M Groom; Scott Petersen; Amanda Henry; Joanne M Said; Sean Seeho; Stefan C Kane; Stephen Tong; Natalie J Hannan
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

8.  Two novel heterozygous truncating variants in NR4A2 identified in patients with neurodevelopmental disorder and brief literature review.

Authors:  Xiaozhen Song; Wuhen Xu; Man Xiao; Yanfen Lu; Xiaoping Lan; Xiaojun Tang; Nanjie Xu; Guangjun Yu; Hong Zhang; Shengnan Wu
Journal:  Front Neurosci       Date:  2022-08-03       Impact factor: 5.152

9.  Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells.

Authors:  Haena Moon; Seong Gak Jeon; Jin-Il Kim; Hyeon Soo Kim; Sangho Lee; Dongok Kim; Seungjoon Park; Minho Moon; Hyunju Chung
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.